[1] 方峰. 巨细胞病毒感染诊断方案.中华儿科杂志,1999,15(7):441-441. [2] 林少勇,王波,唐远平. 更昔洛韦联合丙种球蛋白治疗婴儿巨细胞病毒性肝炎疗效观察. 中华妇幼临床医学杂志电子版,2010,6(3):182-184. [3] Nakase H,Herfarth H.Cytomegalovirus colitis,cytomegalovirus hepatitis and systemic cytomegalovirus infection:common features and differences. Inflamm Intest Dis,2016,1(1):15-23. [4] Honar N,Imanieh MH,Dehghani SM.Evaluation of cytomegal-ovirus infection after six months of liver transplantation in children in shiraz,southern iran. Int J Organ Transplant Med,2011,2(1):20-24. [5] Furuichi M,Fujiwara T,Fukuda A,et al.Fulminant hepatic failure as a risk factor for cytomegalovirus infection in children receiving preemptive therapy after living donor liver transplantation. Transplantation,2016,100(11):2404-2409. [6] Wang G,Feng D.Dynamic relationship between infantile hepatitis syndrome and cytomegalovirus infection. Exp Ther Med,2017,13(6):3443-3447. [7] 侯林毅,赵骞,舒静. 更昔洛韦联合门冬氨酸鸟氨酸治疗婴儿巨细胞病毒性肝炎疗效观察. 中国综合临床,2012,28(5):546-549. [8] White AL,Hedlund GL,Bale JF,et al.Congenital cytomegalovirus infection and brain clefting.Pediat Neurol,2014,50(3):218-223. [9] 李思杰. 更昔洛韦在新生儿先天性巨细胞病毒感染中的临床研究. 中华实验和临床感染病杂志电子版,2011,5(3):52-53. |